Efficacy and safety of pembrolizumab and radiotherapy in relapsed/ refractory cutaneous T cell lymphoma: results of the PORT trial
Morris, S. Scarisbrick, J. Arumainathan, A. Bates, A. Cheadle, E. Collins, G. Cowan, R. El-Mehidi, N. O'Rourke, N. Osbourne, W.
Morris, S.
Scarisbrick, J.
Arumainathan, A.
Bates, A.
Cheadle, E.
Collins, G.
Cowan, R.
El-Mehidi, N.
O'Rourke, N.
Osbourne, W.
Citations
Altmetric:
Abstract
Description
Date
2024
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Morris S, Scarisbrick J, Arumainathan A, Bates A, Cheadle E, Collins G, et al. Efficacy and safety of pembrolizumab and radiotherapy in relapsed/ refractory cutaneous T cell lymphoma: results of the PORT trial. EUROPEAN JOURNAL OF CANCER. 2024 OCT;211:S22-S3. PubMed PMID: WOS:001330761900048. English.